<DOC>
	<DOCNO>NCT02300506</DOCNO>
	<brief_summary>The objective study determine survival status patient enrol study GLI01S ( all-case observational study ) .</brief_summary>
	<brief_title>Post-Marketing Surveillance Long-Term Observation Gliadel Wafer-Investigation Vital Prognosis Patients With High Grade Glioma</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>Inclusion criterion : Malignant Glioma , patient enrol study GLI01S . Exclusion criterion : Corresponding contraindication Gliadel . Not applicable indication Gliadel .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Malignant Glioma</keyword>
	<keyword>Glioblastoma multiforme</keyword>
</DOC>